Full-text search

Results for “Pearl Therapeutics”

Search across the indexed text of every released document.

Names that match “Pearl Therapeutics”

Judea Pearl · 10 Pearl Therapeutics · 2 Durata Therapeutics · 2 Pearl Harbor · 1 Intrinsic Therapeutics · 1 Sirna Therapeutics · 1

86 documents found

Inc. Therapeutics 2006 10.8 - - - - - NM

document Artisan Pharma House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 10.8 - - - - - NM

Inc. Therapeutics 2006 8.2 64 - 64 0.78 0.78 -11.8%

document Barrier Therapeutics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 8.2 64 - 64 0.78 0.78 -11.8%

Inc. Therapeutics 2005 8.0 43.4 - 43.4 5.42 5.42 197.3%

document Cerexa House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2005 8.0 43.4 - 43.4 5.42 5.42 197.3%

Inc. Therapeutics 2007 28.9 72.3 17.3 89.6 2.50 3.10 33.1%

document Pearl Therapeutics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2007 28.9 72.3 17.3 89.6 2.50 3.10 33.1%

Inc. Therapeutics 2008 10.7 19.2 22.5. 41.7 1.79 3.89 42.0%

document Stromedix House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2008 10.7 19.2 22.5. 41.7 1.79 3.89 42.0%

Inc Therapeutics 2005 15.6 7.1 - 7.1 0.46 0.46 -11.5%

document Transcept Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc Therapeutics 2005 15.6 7.1 - 7.1 0.46 0.46 -11.5%

Inc. Therapeutics 2006 6.2 - 6.8 6.8 - 1.11 1.5%

document Concert Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 6.2 - 6.8 6.8 - 1.11 1.5%

Inc. Therapeutics 2007 36.9 - 186.9 186.9 - 5.06 39.9%

document Intarcia Therapeutics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2007 36.9 - 186.9 186.9 - 5.06 39.9%

Inc. Therapeutics 2007 23.7 - 61.8 61.8 - 2.60 27.5%

document Relypsa House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2007 23.7 - 61.8 61.8 - 2.60 27.5%

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

document Tioga Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

document VaxInnate House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

Inc. Therapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2%

document Cephalon House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2%

Inc. Therapeutics 1998 19.9 41 - 41 0.20 0.20 -30.3%

document Deltagen House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 1998 19.9 41 - 41 0.20 0.20 -30.3%

Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3%

document SGX House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3%

and anti-CIA crony, and the coauthor of Flynn’s book, whose daughter now worked for

document IMAGES-005-HOUSE_OVERSIGHT_019963.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…e same room where Japanese diplomats waited to meet with Secretary of State Cordell Hull as he learned of the attack on Pearl Harbor. To all outward appearances, it was an uneventful background interview, and DeYoung, Columbo-like in her affect, aroused no suspicions when she br...